Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

Hepatitis B remains one of the major global health problems more than 40 years after the
identification of human hepatitis B virus (HBV) as the causative agent. A critical turning point …

Virus-like particle (VLP) technology is a promising approach for the construction of novel
vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived …

Helicobacter pylori (H. pylori) is a highly successful human pathogen that colonizes stomach
in around 50% of the global population. The colonization of bacterium induces an …

Helicobacter pylori (H. pylori) is a resident bacterium in the stomach that accounts for 75%
cases of gastric cancer. In this review, we comprehensively studied published papers on H …

Helicobacter pylori has grown to colonize inside the stomach of nearly half of the world's
population, turning into the most prevalent infections in the universe. Medical care failures …

Hepatitis C virus (HCV) infection with associated chronic liver diseases is a major health
problem worldwide. Here, we designed hepatitis B virus (HBV) small surface antigen …

Helicobacter pylori is a human pathogen that infects almost half of the population. Antibiotic
resistance in H. pylori threatens health and increases the demand for prophylactic and …

KISS1 gene-encoding kisspeptins are critical for the onset of puberty and control of adult
fertility. This study investigated whether KISS1 can be used as a novel target for …

Chlamydia trachomatis is the leading cause of sexually transmitted infections worldwide.
There is currently no commercially available vaccine against C. trachomatis. Major outer …